Lundbeck ^Investor

Lundbeck is a global pharmaceutical company dedicated to improving the lives of individuals with psychiatric and neurological disorders. With a focus on research and development, Lundbeck develops innovative products to treat diseases such as depression, schizophrenia, Parkinson's disease, and Alzheimer's disease. The company has research facilities in Denmark and China, employing over 1,000 R&D specialists. Lundbeck collaborates with strategic partners worldwide to ensure the development of new treatment solutions. With approximately 5,300 employees and products registered in over 100 countries, Lundbeck is committed to addressing the unmet needs in psychiatric and neurological disorders.